KR100292299B1 - Microorganism producing glutamic acid and process for preparation glutamic acid using the same - Google Patents
Microorganism producing glutamic acid and process for preparation glutamic acid using the same Download PDFInfo
- Publication number
- KR100292299B1 KR100292299B1 KR1019990009675A KR19990009675A KR100292299B1 KR 100292299 B1 KR100292299 B1 KR 100292299B1 KR 1019990009675 A KR1019990009675 A KR 1019990009675A KR 19990009675 A KR19990009675 A KR 19990009675A KR 100292299 B1 KR100292299 B1 KR 100292299B1
- Authority
- KR
- South Korea
- Prior art keywords
- glutamic acid
- strain
- corynebacterium glutamicum
- culture
- medium
- Prior art date
Links
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 title claims abstract description 36
- 235000013922 glutamic acid Nutrition 0.000 title claims abstract description 36
- 239000004220 glutamic acid Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 6
- 244000005700 microbiome Species 0.000 title abstract description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 20
- CXABZTLXNODUTD-UHFFFAOYSA-M 3-fluoropyruvate Chemical compound [O-]C(=O)C(=O)CF CXABZTLXNODUTD-UHFFFAOYSA-M 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 239000002699 waste material Substances 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 3
- 239000002609 medium Substances 0.000 description 22
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 238000011218 seed culture Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 239000004202 carbamide Substances 0.000 description 8
- 235000013379 molasses Nutrition 0.000 description 8
- 238000011534 incubation Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 229910000358 iron sulfate Inorganic materials 0.000 description 6
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 229940099596 manganese sulfate Drugs 0.000 description 6
- 239000011702 manganese sulphate Substances 0.000 description 6
- 235000007079 manganese sulphate Nutrition 0.000 description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 6
- 229960000344 thiamine hydrochloride Drugs 0.000 description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 6
- 239000011747 thiamine hydrochloride Substances 0.000 description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 239000011616 biotin Substances 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000037353 metabolic pathway Effects 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Abstract
본 발명은 글루탐산 생산 미생물 및 이를 이용한 글루탐산의 생산방법에 관한 것으로 친주인 코리네박테리움 글루타미쿰(Corynebacterium glutamicum) KFCC 10656를 변이처리하여 얻은 변이균주 코리네박테리움 글루타미쿰 BL2는 β-플루오로피루베이트 내성을 가지며 친주에 비해 글루탐산을 고수율로 생산하는 뛰어난 효과가 있다.The present invention relates to a glutamic acid-producing microorganism and a method for producing glutamic acid using the same. It is resistant to ropyruvate and has an excellent effect of producing glutamic acid in high yield compared to parent strain.
Description
본 발명은 글루탐산 생산 미생물 및 이를 이용한 글루탐산의 생산방법에 관한 것이다. 더욱 상세하게는, 코리네박테리움 글루타미컴(Corynebacterium glutamicum) KFCC 10656의 변이주로 β-플루오로피루베이트 내성을 보유하며 글루탐산의 생산능이 우수한 미생물 및 이를 이용한 글루탐산 제조방법에 관한 것이다.The present invention relates to a glutamic acid producing microorganism and a method for producing glutamic acid using the same. More specifically, the present invention relates to a microorganism having a β-fluoropyruvate resistance and excellent glutamic acid production ability and a glutamic acid manufacturing method using the same as a variant of Corynebacterium glutamicum KFCC 10656.
글루탐산 생성 대사 경로상에서 피루베이트는 대사의 중간 물질이며 글루탐산 생성의 전구체를 공급하는 시트르산 회로의 도입물질의 역할을 하는 것으로 알려져 있다. 실제로 글루탐산 대사 경로상에서 피루베이트는 결과적으로는 시트르산 회로의 중간 물질들로부터 생산되는 아미노산들의 전구물질을 제공한다. 이러한 대사 중간물질로서의 역할 때문에 대사 경로중의 피루베이트량이 증가하게 되면 중간 대사산물저해(feedback inhibition)에 의해 피루베이트 생성에 관여하는 효소의 활성이 억제되어 시트르산 회로에 공급될수 있는 피루베이트량이 감소하고 이에 따라 아미노산 생성에 요구되는 대사 중간 물질들도 감소하게 된다. 따라서 시트르산 회로에서 전구물질들을 공급받는 아미노산들의 생산량을 늘리기 위해서는 시트르산 회로의 원활한 순환이 필요하며 시트르산 회로의 시작 물질인 피루베이트의 공급이 중요하다. 그러나 일반적인 균주의 대사 경로에서는 일정 수준 이상의 피루베이트가 생성되지 않도록 대사 산물 저해 기작이 존재하므로 과량의 피루베이트가 대사상에서 생성되도록 하기 위해서는 이러한 조절 기작을 해제할 필요성이 있다. 따라서 본 발명자들은 상기와 같은 점에 착안하여 종래 미생물의 형질을 변형시켜서 β-플루오로피루베이트에 내성을 갖는 변이주 즉, 피루베이트 생성량 조절 능력이 해제된 균주를 얻었으며 상기 변이주가 대사상에서 과량의 피루베이트 생성이 가능하며 시트르산 회로상에서 글루탐산 생산의 전구물질인 α-케토글루타르산의 생성량을 증가시켜 최종적으로는 글루탐산의 생산량을 증가시킴을 확인하므로써 본 발명을 완성하였다.Pyruvate on glutamic acid production metabolic pathways is known to be an intermediate of metabolism and to serve as an introduction material of the citric acid cycle to supply precursors of glutamic acid production. In fact, pyruvate on the glutamic acid metabolic pathway results in a precursor of amino acids produced from intermediates in the citric acid cycle. Due to its role as a metabolic intermediate, an increase in the amount of pyruvate in the metabolic pathway inhibits the activity of enzymes involved in pyruvate production by intermediate metabolite inhibition, thereby reducing the amount of pyruvate that can be supplied to the citric acid cycle. This reduces the metabolic intermediates required for amino acid production. Therefore, in order to increase the production of amino acids that receive precursors in the citric acid cycle, smooth circulation of the citric acid cycle is required and the supply of pyruvate, the starting material of the citric acid cycle, is important. However, the metabolite inhibition mechanism exists so that a certain level of pyruvate is not generated in the metabolic pathway of the general strain, so it is necessary to release this regulation mechanism so that excess pyruvate is produced in metabolism. Therefore, the present inventors have focused on the above, and modified the traits of conventional microorganisms to obtain a variant strain resistant to β-fluoropyruvate, that is, a strain in which the ability to control pyruvate production was released, and the strain strain was excessive in metabolism. The present invention was completed by confirming that pyruvate can be produced and the production amount of α-ketoglutaric acid, which is a precursor of glutamic acid production on the citric acid cycle, is finally increased to increase the production of glutamic acid.
본 발명의 목적은 공지의 코리네박테리움 글루타미컴(corynebacterium glutamicum)을 변이처리하여 글루탐산 생산능이 향상된 변이주를 제공함에 있다. 본 발명의 다른 목적은 상기 변이주를 당이 함유된 배지중에서 배양하여 고수율로 글루탐산을 채취하는 글루탐산 제조방법을 제공함에 있다.An object of the present invention is to provide a mutant strain with improved glutamic acid production capacity by mutating known Corynebacterium glutamicum. Another object of the present invention is to provide a method for producing glutamic acid by culturing the mutant strain in a medium containing sugar to obtain glutamic acid in high yield.
본 발명의 상기 목적은 코리네박테리움 글루타미컴 KFCC 10656을 친주로 하여 자외선 조사, N-메틸-N'-니트로-N-니트로소구아니딘(NTG) 등의 변이 유발제를 처리하여 β-플루오로피루베이트가 첨가된 배지에서 생육할 수 있는 변이주를 얻은 후 이 변이주의 생화학적 특성을 조사한 다음 상기 친주로 사용한 코리네박테리움 글루타미컴 KFCC 10656와 본 발명 변이주의 배양조건에 따른 글루탐산 생산능을 조사하므로써 달성하였다.The above object of the present invention is a β-fluoro by treating a mutation causing agent such as ultraviolet irradiation, N-methyl-N'-nitro-N-nitrosoguanidine (NTG) with the parent of Corynebacterium glutamicum KFCC 10656 After obtaining a mutant strain that can be grown in a pyruvate-added medium, the biochemical characteristics of the mutant strain were examined, and then the glutamic acid production capacity according to the culture conditions of Corynebacterium glutamicum KFCC 10656 and the mutant strain of the present invention was used as the parent strain. Achieved by investigation.
이하 본 발명의 구성 및 작용을 설명한다.Hereinafter, the configuration and operation of the present invention.
본 발명은 코리네박테리움 글루타미컴 KFCC 10656을 친주로 하여 변이처리한 후 β-플루오로피루베이트가 첨가된 배지에서 생육하는 변이주를 선별한 다음 글루탐산 생산성이 기존 균주보다 향상된 변이주를 선별하고 선별한 균주의 생화학적 특성을 조사하는 단계 및; 상기 선별한 변이균주와 친주인 코리네박테리움 글루타미컴 KFCC 10656를 다양한 배양 조건하에서 배양한 후 각기 균주로부터 생산된 글루탐산 양을 비교분석하는 단계로 구성된다.In the present invention, after mutating treatment with Corynebacterium glutamicum KFCC 10656 as a parent strain, the mutants growing in the medium to which β-fluoropyruvate was added were selected, and then the mutants with improved glutamic acid productivity were selected and selected. Examining the biochemical properties of one strain; After culturing the selected strain and parent strain Corynebacterium glutamicum KFCC 10656 under a variety of culture conditions, and comprises comparing and analyzing the amount of glutamic acid produced from each strain.
이하, 본 발명의 구체적인 방법을 실시예와 비교실시예를 들어 설명하고자 하지만 본 발명의 권리범위는 이들 실시예와 비교실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described with reference to Examples and Comparative Examples, but the scope of the present invention is not limited only to these Examples and Comparative Examples.
실시예 1: 본 발명 변이균주 분리 및 이들의 생화학적 특성Example 1 Isolation of Mutant Strains of the Present Invention and Their Biochemical Properties
제 1단계: 글루탐산 생산 변이균주 선별Step 1: Selection of Glutamic Acid-producing Mutant Strains
코리네박테리움 글루타미컴(Corynebacterium glutamicum) KFCC 10656를 친주로 하여 자외선조사, N-메틸-N`-니트로-N-니트로소구아니딘 (NTG) 등의 변이 유발제를 처리한 후 β-플루오로피루베이트가 농도별로 첨가된 배지에서 생육할 수 있는 변이주를 획득하였다. 이때 사용된 영양배지는 펩톤 1%, 육즙 1%, 염화나트륨 0.25%, 효모엑기스 1%, 한천 2%를 함유하고 pH는 7.2이며, 최소배지는 포도당 10g/L, 인산제1칼륨 1g/L, 인산제2칼륨 0.5g/L, 황산암모늄0.5g/L, 요소 1g/L, 황산철 20mg/L, 황산마그네슘 0.5g/L, 황산망간 20mg/L, 티아민염산염 200㎍/L, 비오틴 200㎍/, 당밀 5g/L를 함유하고 pH는 7.0이고 β-플루오로피루베이트 첨가배지는 상기 최소배지에 β-플루오로피루베이트 5-500mg/L 첨가한 배지를 사용하였으며 사용된 배지중 β-플루오로피루베이트 농도는 500mg/L까지였으며 분리에 성공한 내성주는 100mg/L의 β-플루오로피루베이트 농도에서 생육가능한 것으로 확인되었다. 여기서 얻어진 변이주에 대해 플라스크 실험 및 발효조 배양 실험을 실시한 결과 기존 균주에 비해 글루탐산 생산성이 약 10% 정도 향상되었다. 본 발명자들은 상기 변이 균주를 코리네박테리움 글루타미쿰 BL2라 명명하고 1998년 12월 30일 한국종균협회에 기탁번호 KFCC-11074로 기탁하였다.Corynebacterium glutamicum KFCC 10656 as a parent, β-fluoropyru after treatment with UV-induced mutations such as N-methyl-N`-nitro-N-nitrosoguanidine (NTG) Variant strains were obtained which could be grown in the medium to which bait was added by concentration. The nutrient medium used was 1% peptone, 1% gravy, 0.25% sodium chloride, 1% yeast extract, 2% agar, pH was 7.2, the minimum medium was 10g / L glucose, 1g / L potassium phosphate, 0.5 g / L dipotassium phosphate, 0.5 g / L ammonium sulfate, 1 g / L urea, 20 mg / L iron sulfate, 0.5 g / L magnesium sulfate, 20 mg / L manganese sulfate, 200 µg / L thiamine hydrochloride, 200 µg biotin / Medium containing 5 g / L of molasses and pH of 7.0 and β-fluoropyruvate addition medium used β-fluoropyruvate 5-500 mg / L medium to the minimum medium. The concentration of ropyruvate was up to 500 mg / L and the resistant strains were found to be viable at 100 mg / L β-fluoropyruvate. As a result of the flask experiment and the fermenter culture experiment on the mutant strain obtained, glutamic acid productivity was improved by about 10% compared to the existing strain. The present inventors named the mutant strain Corynebacterium glutamicum BL2 and deposited it on December 30, 1998 with the Accession No. KFCC-11074.
제 2단계: 본 발명 변이균주의 생화학적 특성Second Step: Biochemical Properties of Inventive Mutant Strains
상기 제 1단계에서 분리선별한 본 발명 변이주 코리네박테리움 글루타미쿰 BL2의 생화학적 특성은 표 1, 표 2 및 표3에 기재한 바와 같았다. 즉, β-플루오로피루베이트에 대한 내성과 고농도의 해 삼투압에 의한 영향을 배재할 수 있는 형질인 염화나트륨에도 내성이 높으며 소듐아자이드에도 내성이 높은 변이주임을 알 수 있었다.Biochemical characteristics of the present invention strain Corynebacterium glutamicum BL2 separated in the first step was as described in Table 1, Table 2 and Table 3. In other words, the strain was highly resistant to sodium chloride and resistant to sodium azide and resistant to β-fluoropyruvate and high concentrations of osmotic pressure.
비교실시예 1: 1차 종배양 방법에 따른 본 발명 변이균주와 친주의 글루탐산 생산능 비교Comparative Example 1: Comparison of Glutamic Acid Production Capacity of Mutant and Parent strains of the Invention According to Primary Species Culture
본 비교실시예에서는 펩톤 1%, 효모엑기스 0.5%, 육즙 0.5%, 포도당 1%, 염화나트륨 0.25%, 요소 0.13%를 함유하고 pH 7.2인 종배지 및 포도당 3%, 미액 0.2%, 비오틴 1㎍/L, 폐당밀 0.05%, 황산암모늄 0.1%, 황산철 0.002%, 황산 망간 0.002%, 황산 마그네슘 0.05%, 티아민 염산염 200㎍/L, 인산 제1칼륨 0.2%, 요소0.95%를 함유하고 pH 7.2인 발효배지를 사용하여 본 발명 변이균주 코리네박테리움 글루타미쿰 BL2와 친주 코리네박테리움 글루타미쿰 KFCC 10656를 배양하면서 글루탐산 생산능을 비교하였다. 발효방법은 상기 종배지 3mL을 지름 18mm 시험관에 분주하고 상법에 따라 가압 살균후 사용 균주를 접종하고 30℃ 온도에서 18시간 진탕 배양하여 종배양액으로 사용하였다. 발효배지 40mL을 500mL 진탕용 삼각플라스크에 분주하고 121℃ 온도에서 10분간 가압 살균하여 종배양액 1mL을 식균한 다음 48시간 배양하였다. 회전수는 분당 180회, 온도 30℃, pH 7.2로 조절하였다. 실험결과, 배양완료 후 배지내 글루탐산 축적량은 KFCC 10656이 17.2g/L, BL2가 18.9g/L이었다. 이는 본 발명 변이균주 코리네박테리움 글루타미쿰 BL2가 기존 균주에 비해 당농도 3% 배지에서 글루탐산 생산성이 약10% 정도 향상된 것으로 확인되었다.In this comparative example, 1% peptone, 0.5% yeast extract, 0.5% broth, 1% glucose, 0.25% sodium chloride, 0.13% urea, pH 7.2 and 3% glucose, 0.2% undiluted solution, biotin 1µg / L, waste molasses 0.05%, ammonium sulfate 0.1%, iron sulfate 0.002%, manganese sulfate 0.002%, magnesium sulfate 0.05%, thiamine hydrochloride 200 µg / L, potassium potassium phosphate 0.2%, urea 0.95%, pH 7.2 Glutamic acid production ability was compared while culturing the present invention mutant strain Corynebacterium glutamicum BL2 and parent strain Corynebacterium glutamicum KFCC 10656. The fermentation method was dispensed 3mL of the seed medium in a test tube with a diameter of 18mm, inoculated using strain after autoclaving according to a conventional method, and used as a seed culture solution by incubating shaking culture at 30 ° C. for 18 hours. 40 mL of the fermentation broth was dispensed into a 500 mL shaking flask for shaking, and sterilized by autoclaving at 121 ° C. for 10 minutes to inoculate 1 mL of the seed culture solution and incubated for 48 hours. Rotation speed was adjusted to 180 times per minute, temperature 30 ℃, pH 7.2. As a result, the accumulation amount of glutamic acid in the culture medium after completion of culture was 17.2 g / L for KFCC 10656 and 18.9 g / L for BL2. This mutant strain Corynebacterium glutamicum BL2 of the present invention was found to be about 10% improved glutamic acid productivity in a 3% medium of glucose concentration compared to the existing strain.
비교실시예 2: 2차 종배양 방법에 따른 본 발명 변이균주와 친주의 글루탐산 생산능 비교Comparative Example 2: Comparison of Glutamic Acid Production Capacity of Mutant and Parent strains of the Invention According to Secondary Species Culture
본 비교실시예에서는 펩톤 1%, 효모 엑기스 0.7%, 육즙 0.7%, 포도당 1%, 자당 1%, 염화나트륨 0.25%, 요소 0.3%, 페놀레드 0.001%를 함유하고 pH가 7.2인 1차 종배지와 원당 3%, 포도당 1%, 과당 1%, 황산 마그네슘 0.04%, 인산 제 1칼륨 0.1%, 인산 제2칼륨 0.05%, 황산 암모늄 0.8%, 황산철 0.002%, 황산망간 0.002%, 황산아연 0.0002%, 황산구리 0.0002%, 비오틴 500㎍/L, 티아민 염산염 2mg/L, 대두단백 가수분해물 0.2%, 페놀레드 0.001%를 함유하고 pH가 6.8인 2차 종배지 및 자당 6%, 포도당 2%, 과당 2%, 황산 마그네슘 0.05%, 인산 제 1칼륨 0.05%, 인산 제 2칼륨 0.15%, 황산 암모늄 0.1%, 황산철 0.002%, 황산망간 0.002%, 황산아연 0.0002%, 황산구리 0.0002%, 비오틴 30㎍/L, 티아민 염산염 1mg/L, 대두단백 가수분해물 0.2%, 페놀레드 0.001%, 탄산칼슘 3%를 함유하고 pH 6.75인 발효배지를 사용하여 본 발명 변이균주 코리네박테리움 글루타미쿰 BL2와 친주 코리네박테리움 글루타미쿰 KFCC 10656를 배양하면서 글루탐산 생산능을 비교하였다. 즉, 1차 종배양은 상기 1차 종배양 배지 2.5mL을 18mm 시험관에 분주하고 121℃에서 5분간 가압살균하여 냉각한 후 사용균주를 접종하고 30℃에서 분당 160회의 회전수로 12시간 진탕배양하였다. 2차 종배양은 2차 종배지 30mL을 250mL 진탕용 삼각플라스크에 분주하고 121℃에서 5분간 가압살균 및 냉각하여 1차 종배양액의 배양완료액을 1mL 접종한 후 31℃에서 150rpm으로 14시간 진탕 배양하였다. 발효방법은 상기 발효배지를 250mL 삼각 플라스크에 30mL씩 분주하고, 10% 요소 용액 1mL을 첨가한 후 2차 종배양액 5mL을 접종한 후 31℃에서 150rpm으로 36시간 배양하였다. 배양 중간에 pH에 따라 10% 요소수용액 8mL을 수시로 첨가하여, pH 조절 및 질소원을 공급하였다. 발효시작 2시간 경과 후 계면 활성제 0.04%와 페니실린 0.3U/mL을 첨가한 후 당이 모두 소모될때까지 배양하였다. 배양완료 후 글루탐산의 농도는 KFCC 10656이 46.8g/L, BL2가 53.2g/L였다.In this comparative example, the primary seed medium containing 1% peptone, 0.7% yeast extract, 0.7% juice, 1% glucose, 1% sucrose, 0.25% sodium chloride, 0.3% urea, 0.001% phenol red, and pH 7.2 Raw sugar 3%, glucose 1%, fructose 1%, magnesium sulfate 0.04%, potassium phosphate 0.1%, dipotassium phosphate 0.05%, ammonium sulfate 0.8%, iron sulfate 0.002%, manganese sulfate 0.002%, zinc sulfate 0.0002% , Secondary species medium containing 0.0002% copper sulfate, 500 μg / L biotin, 2 mg / L thiamine hydrochloride, 0.2% soy protein hydrolysate, 0.001% phenol red and 0.001% pH 6, sucrose 6%, glucose 2%, fructose 2 %, Magnesium sulfate 0.05%, potassium monophosphate 0.05%, potassium diphosphate 0.15%, ammonium sulfate 0.1%, iron sulfate 0.002%, manganese sulfate 0.002%, zinc sulfate 0.0002%, copper sulfate 0.0002%, biotin 30µg / L The modified strain of the present invention using a fermentation broth containing 1 mg / L thiamine hydrochloride, 0.2% soy protein hydrolyzate, 0.001% phenol red and 3% calcium carbonate and having a pH of 6.75 While cultivating tumefaciens glutamicum BL2 and the parent strain Corynebacterium glutamicum KFCC 10656 compared glutamic acid-producing ability. That is, the primary seed culture is 2.5mL of the primary seed culture medium in an 18 mm test tube, cooled by autoclaving at 121 ° C. for 5 minutes, inoculated with the strain, and incubated for 12 hours at 30 ° C. at 160 revolutions per minute. It was. In the secondary seed culture, 30 mL of the secondary seed medium was dispensed into a 250 mL shaking Erlenmeyer flask, pressurized and cooled at 121 ° C. for 5 minutes, inoculated with 1 mL of the culture medium of the primary seed culture solution, and shaken at 31 ° C. at 150 rpm for 14 hours. Incubated. In the fermentation method, 30 mL of the fermentation medium was dispensed in 250 mL Erlenmeyer flasks, 1 mL of 10% urea solution was added, and 5 mL of the secondary seed culture solution was inoculated, followed by incubation at 150 ° C. at 31 ° C. for 36 hours. 8 mL of 10% urea aqueous solution was added from time to time according to the pH in the middle of the culture, so as to adjust the pH and supply nitrogen source. After 2 hours from the start of fermentation, 0.04% of surfactant and 0.3U / mL of penicillin were added, and then cultured until all of the sugar was consumed. After incubation, the concentration of glutamic acid was 46.8 g / L for KFCC 10656 and 53.2 g / L for BL2.
비교실시예 3: 상기와 다른 조건의 2차 종배양 방법에 따른 본 발명 변이균주와 친주의 글루탐산 생산능 비교Comparative Example 3: Comparison of Glutamic Acid Production Capacity of Mutant and parent strains of the Invention According to Secondary Cultivation Methods Under Different Conditions
본 비교실시예에서는 펩톤 0.7%, 효모엑기스 0.7%, 육즙 0.7%, 포도당 1%, 염화나트륨 0.25%, 요소 0.13%, 황산 암모늄 0.1%를 함유하고 pH 7.5인 1차 종배지와 원당 3%, 당밀 1%, 황산마그네슘 0.04%, 인산제2칼륨 0.1%, 황산 암모늄 0.3%, 황산철 0.001%, 황산망간 0.001%, 비오틴 500㎍/L, 티아민 염산염 2mg/L, 요소 0.1%를 함유하고 pH 7.1인 2차 종배지 및 원당 1.7%, 당밀 6.8%, 인산 0.13%, 황산마그네슘 0.04%, 황산철 0.001%, 황산망간 0.001%, 미액 0.1%, 티아민 염산염 200㎍/L, 수산화칼륨 0.18%, 소포제 0.005%를 함유하고 pH 7.5인 발효배지를 사용하여 본 발명 변이균주 코리네박테리움 글루타미쿰 BL2와 친주 코리네박테리움 글루타미쿰 KFCC 10656를 배양하면서 글루탐산 생산능을 비교하였다. 1차 종배양은 1차 종배지 40mL을 500mL 진탕용 삼각 플라스크에 분주하고 121℃에서 10분간 가압 살균하여 냉각 후 균주를 접종하여 회전수 분당 180회, 30℃에서 20시간 진탕 배양하였다. 2차 종배양은 2차 종배지를 5리터 용량의 실험용 발효조에 2.5리터씩 분주하고 121℃에서 10분간 가압살균한후 냉각시켜 1차 종배양액의 배양완료액을 30mL 접종한후 공기를 매분당 0.5리터 공급하면서 900rpm, 30℃에서 18시간 진탕 배양하였다. 발효방법은 상기 발효배지를 30리터 용량의 시험발효조에 9리터씩 분주하고 121℃에서 10분간 가압살균한 뒤 냉각하여 2차 종배양액을 약 1.5리터씩 접종한 후, 공기를 매분당 2.5리터씩 공급하면서 450rpm, 31℃에서 배양하였다. 상기 조건으로 배양하여 대수증식기 초기 내지 말기 사이에 페니실린 혹은 계면활성제를 첨가하고 배양하며 배양중 발효액의 pH는 28% 암모니아수로 pH 7.7이 되도록 계속 조절하였다. 배양중 잔당의 농도가 1.5%되면 살균된 폐당밀 또는 폐당밀과 원당을 일정한 비율로 혼합한 당을 수시로 공급하였다. 추가로 당밀 또는 혼합당과의 초기의 발효배지에 첨가된 당의 합계가 발효액량 대비 22%가 될 때까지 계속 배양하였다. 실험결과, 배양완료 후 글루탐산의 농도는 KFCC10656이 139.5g/L, BL2가 151.7g/L이었다.In this comparative example, a primary seed medium containing 0.7% peptone, 0.7% yeast extract, 0.7% juice, 1% glucose, 0.25% sodium chloride, 0.13% urea, 0.1% ammonium sulfate and pH 7.5, 3% molasses and molasses 1%, magnesium sulfate 0.04%, potassium dibasic phosphate 0.1%, ammonium sulfate 0.3%, iron sulfate 0.001%, manganese sulfate 0.001%, biotin 500 μg / L, thiamine hydrochloride 2 mg / L, urea 0.1%, pH 7.1 Phosphorus secondary seed medium and raw sugar 1.7%, molasses 6.8%, phosphoric acid 0.13%, magnesium sulfate 0.04%, iron sulfate 0.001%, manganese sulfate 0.001%, fine liquid 0.1%, thiamine hydrochloride 200µg / L, potassium hydroxide 0.18%, defoamer Glutamic acid production ability was compared while culturing the present invention variant strain Corynebacterium glutamicum BL2 and parent strain Corynebacterium glutamicum KFCC 10656 using a fermentation medium containing 0.005% and pH 7.5. In the primary seed culture, 40 mL of the primary seed medium was dispensed into a 500 mL shaking Erlenmeyer flask, pressurized and sterilized at 121 ° C. for 10 minutes, inoculated with the strain after cooling, and incubated at 180 ° C. per minute and shaken at 30 ° C. for 20 hours. In the secondary seed culture, the secondary seed medium was divided into 2.5 liters into a 5-liter experimental fermenter, pressurized and sterilized at 121 ° C. for 10 minutes, cooled, and inoculated with 30 mL of the primary seed culture incubation liquid, followed by air per minute. Shaking culture was performed for 18 hours at 900 rpm, 30 ℃ while feeding 0.5 liter. In the fermentation method, the fermentation broth is dispensed in 9 liters into a 30 liter test fermentation tank, pressurized and sterilized at 121 ° C. for 10 minutes, cooled, and then inoculated with a secondary seed culture solution of about 1.5 liters, followed by 2.5 liters of air per minute. It was incubated at 450 rpm, 31 ° C with feeding. Incubated under the above conditions, penicillin or surfactant was added between the beginning and end of the logarithmic growth phase, and the culture was continued to adjust the pH of the fermentation broth to pH 7.7 with 28% ammonia water. When the concentration of the residual sugar in the culture was 1.5%, a sterile waste molasses or a mixture of waste molasses and raw sugar was supplied at a constant rate. Further culture was continued until the sum of the sugars added to the initial fermentation medium with molasses or mixed sugar was 22% of the amount of fermentation broth. As a result, the concentration of glutamic acid after incubation was 139.5 g / L for KFCC10656 and 151.7 g / L for BL2.
이상, 상기 실시예와 비교실시예를 통하여 설명한 바와 같이 친주인 코리네박테리움 글루타미쿰 KFCC 10656를 변이처리하여 얻은 본 발명 변이균주 코리네박테리움 글루타미쿰 BL2는 β-플루오로피루베이트 내성을 가지며 친주에 비해 글루탐산을 고수율로 생산하는 뛰어난 효과가 있으므로 발효 및 식품 산업상 매우 유용한 발명인 것이다.As described above, the mutant strain Corynebacterium glutamicum BL2 of the present invention obtained by mutating the parent strain Corynebacterium glutamicum KFCC 10656 as described through the above Examples and Comparative Examples is β-fluoropyruvate resistant. It is a very useful invention in the fermentation and food industry because it has an excellent effect of producing glutamic acid in high yield compared to the parent.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990009675A KR100292299B1 (en) | 1999-03-22 | 1999-03-22 | Microorganism producing glutamic acid and process for preparation glutamic acid using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990009675A KR100292299B1 (en) | 1999-03-22 | 1999-03-22 | Microorganism producing glutamic acid and process for preparation glutamic acid using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000060972A KR20000060972A (en) | 2000-10-16 |
KR100292299B1 true KR100292299B1 (en) | 2001-06-01 |
Family
ID=19577294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990009675A KR100292299B1 (en) | 1999-03-22 | 1999-03-22 | Microorganism producing glutamic acid and process for preparation glutamic acid using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100292299B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013081296A1 (en) | 2011-12-01 | 2013-06-06 | 씨제이제일제당 (주) | Microorganism for simultaneously producing l-amino acid and riboflavin, and method for producing l-amino acid and riboflavin using same |
WO2019172702A1 (en) | 2018-03-09 | 2019-09-12 | 씨제이제일제당 (주) | Novel promoter and l-amino acid production method using same |
WO2019190193A1 (en) | 2018-03-27 | 2019-10-03 | 씨제이제일제당 (주) | Microorganism having enhanced glycine productivity and method for producing fermented composition by using same |
WO2021150029A1 (en) | 2020-01-21 | 2021-07-29 | 씨제이제일제당 (주) | Method for producing l-amino acid by using microorganism containing nadp dependent glyceraldehyde-3-phosphate dehydrogenase |
WO2022055094A1 (en) | 2020-09-09 | 2022-03-17 | 씨제이제일제당 (주) | Recombinant microorganism for producing l-glutamic acid, and l-glutamic acid production method using same |
WO2023277307A1 (en) | 2021-06-30 | 2023-01-05 | 씨제이제일제당 (주) | Strain for producing highly concentrated l-glutamic acid, and l-glutamic acid production method using same |
WO2023008862A1 (en) | 2021-07-26 | 2023-02-02 | 씨제이제일제당 (주) | Microorganism having weakened activity of laci family dna-binding transcriptional regulator, and l-glutamic acid production method using same |
WO2023048480A1 (en) | 2021-09-23 | 2023-03-30 | Cj Cheiljedang Corporation | Strain for producing high concentration l-glutamic acid and method for producing l-glutamic acid using the same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100824457B1 (en) | 2006-10-16 | 2008-04-22 | 씨제이제일제당 (주) | A microorganism producing Glutamic acid in high yield and a process of producing Glutamic acid using the same |
CN113950525B (en) * | 2021-01-27 | 2022-06-03 | Cj第一制糖株式会社 | Novel ribonuclease P variants and method for producing L-glutamic acid using the same |
-
1999
- 1999-03-22 KR KR1019990009675A patent/KR100292299B1/en not_active IP Right Cessation
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013081296A1 (en) | 2011-12-01 | 2013-06-06 | 씨제이제일제당 (주) | Microorganism for simultaneously producing l-amino acid and riboflavin, and method for producing l-amino acid and riboflavin using same |
WO2019172702A1 (en) | 2018-03-09 | 2019-09-12 | 씨제이제일제당 (주) | Novel promoter and l-amino acid production method using same |
US11352608B2 (en) | 2018-03-09 | 2022-06-07 | Cj Cheiljedang Corporation | Promoter and a method for producing L-amino acid using the same |
WO2019190193A1 (en) | 2018-03-27 | 2019-10-03 | 씨제이제일제당 (주) | Microorganism having enhanced glycine productivity and method for producing fermented composition by using same |
EP4130281A1 (en) | 2018-03-27 | 2023-02-08 | CJ Cheiljedang Corporation | Microorganism having increased glycine productivity and method for producing fermented composition using the same |
WO2021150029A1 (en) | 2020-01-21 | 2021-07-29 | 씨제이제일제당 (주) | Method for producing l-amino acid by using microorganism containing nadp dependent glyceraldehyde-3-phosphate dehydrogenase |
WO2022055094A1 (en) | 2020-09-09 | 2022-03-17 | 씨제이제일제당 (주) | Recombinant microorganism for producing l-glutamic acid, and l-glutamic acid production method using same |
WO2023277307A1 (en) | 2021-06-30 | 2023-01-05 | 씨제이제일제당 (주) | Strain for producing highly concentrated l-glutamic acid, and l-glutamic acid production method using same |
WO2023008862A1 (en) | 2021-07-26 | 2023-02-02 | 씨제이제일제당 (주) | Microorganism having weakened activity of laci family dna-binding transcriptional regulator, and l-glutamic acid production method using same |
WO2023048480A1 (en) | 2021-09-23 | 2023-03-30 | Cj Cheiljedang Corporation | Strain for producing high concentration l-glutamic acid and method for producing l-glutamic acid using the same |
Also Published As
Publication number | Publication date |
---|---|
KR20000060972A (en) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8361758B2 (en) | Microorganism of Corynebacterium genus having resistance to kanamycin and enhanced L-lysine productivity and method of producing L-lysine using the same | |
KR100292299B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
JPH04262790A (en) | Production of 5'-xanthylic acid by fermentation | |
EP0745679B1 (en) | A method for producing L-isoleucine with a fermentation process and L-homoserine as the sole nitrogen source | |
KR20000013852A (en) | Preparation method of l-threonine from e.coli dsm 9806(kccm-10133) | |
US7608435B2 (en) | Microorganism producing 5′-xanthylic acid | |
KR100402320B1 (en) | A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same | |
KR100317901B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
KR100292298B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
US6133000A (en) | Fermentative preparation of amino acids | |
US7456010B2 (en) | Microorganism producing 5′-xanthylic acid | |
KR100317902B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
US7217558B2 (en) | Microorganism producing 5'xanthylic acid | |
KR100402322B1 (en) | A microorganism Corynebacterium ammoniagenes CJXP002 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same | |
KR100376537B1 (en) | Microorganism Corynebacterium glutamicum producing L-lysine and process for producing L-lysine by use thereof | |
KR20000002408A (en) | Glutamic acid producible microorganism and preparation method of glutamic acid by using it | |
KR900007948B1 (en) | Novel microorganism for producing of glutamic acid | |
KR910007856B1 (en) | Method for producing l-glutamic acid | |
HU215184B (en) | Process for the production of 1-lysine and l-lysine producing mutant brevibacteria and corynebacteria | |
KR900007946B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007947B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007938B1 (en) | Novel microorganism for producing of glutamic acid | |
KR20070057093A (en) | A microorganism of corynebacterium genus having enhanced l-lysine productivity resistant to kanamycin and a method of producing l-lysine using the same | |
JPS6324679B2 (en) | ||
JPS61260891A (en) | Production of l-threonine by fermentation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20080103 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |